| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Neuropathology [M. W., G. R.] and Dermatology [J. R., T. R.] and Center for Biological and Medical Research [G.R., T.R.], Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, and Department of Neuropathology, Ruprecht-Karls-University, 69120 Heidelberg [C.S.], Germany
The human homologue of the Drosophila segment polarity gene patched (PTCH) has recently been identified as the tumor suppressor gene responsible for the nevoid basal cell carcinoma (BCC) syndrome (H. Hahn et al., Cell, 85: 841851, 1996; R. L. Johnson et al., Science (Washington DC), 272: 16681671, 1996). In addition to multiple BCCs, patients with nevoid BCC syndrome have a predisposition for the development of primitive neuroectodermal tumors (PNETs) of the central nervous system. We have analyzed 9 sporadic BCCs and 37 PNETs for mutation and expression of the PTCH gene. PTCH mutations were found in 3 BCCs (33.3%) and in 5 PNETs (14%), including 1 of 5 cerebral PNETs, 2 of 15 medulloblastomas, and 2 of 17 desmoplastic medulloblastomas. The sequence changes in six of these tumors (four PNETs, two BCCs) were mutations predicted to result in truncated proteins. Missense mutations were detected in one PNET and one BCC each. In addition, novel sequence polymorphisms were found in exon 2, intron 5, intron 10, and intron 14 of PTCH. Reverse transcription-PCR analysis revealed increased PTCH expression levels compared to nonneoplastic brain tissue and normal skin in the majority of PNETs and BCCs investigated. Our data suggest that genetic alterations of PTCH are not only of significance in hereditary and sporadic BCCs but are also involved in the molecular pathogenesis of a subset of sporadic central nervous system PNETs.
1 Supported by Grant Re 938/2-1 from the Deutsche Forschungsgemeinschaft and Grant 10-0976-Re1 from the Deutsche Krebshilfe.
2 To whom requests for reprints should be addressed. Phone: 49 211 8118662; Fax: 49 211 8117804; E-mail: reifenb@rz.uni-duesseldorf.de.
Received 4/ 7/97. Accepted 5/14/97.
This article has been cited by other articles:
![]() |
R. J. Ward, L. Lee, K. Graham, T. Satkunendran, K. Yoshikawa, E. Ling, L. Harper, R. Austin, E. Nieuwenhuis, I. D. Clarke, et al. Multipotent CD15+ Cancer Stem Cells in Patched-1-Deficient Mouse Medulloblastoma Cancer Res., June 1, 2009; 69(11): 4682 - 4690. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Besaratinia, S.-i. Kim, and G. P. Pfeifer Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells FASEB J, July 1, 2008; 22(7): 2379 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, M. A. Grotzer, T. Watanabe, E. Hewer, T. Pietsch, S. Rutkowski, and H. Ohgaki Mutations in the Nijmegen Breakage Syndrome Gene in Medulloblastomas Clin. Cancer Res., July 1, 2008; 14(13): 4053 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Dirks Brain Tumor Stem Cells: Bringing Order to the Chaos of Brain Cancer J. Clin. Oncol., June 10, 2008; 26(17): 2916 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-S. Sun, X.-F. Li, and T.-J. Li PTCH1 and SMO Gene Alterations in Keratocystic Odontogenic Tumors Journal of Dental Research, June 1, 2008; 87(6): 575 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hambardzumyan, O. J. Becher, M. K. Rosenblum, P. P. Pandolfi, K. Manova-Todorova, and E. C. Holland PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo Genes & Dev., February 15, 2008; 22(4): 436 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B Dirks Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells Phil Trans R Soc B, January 12, 2008; 363(1489): 139 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. de Bont, R. J. Packer, E. M. Michiels, M. L. d. Boer, and R. Pieters Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective Neuro-oncol, January 1, 2008; 10(6): 1040 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Farioli-Vecchioli, M. Tanori, L. Micheli, M. Mancuso, L. Leonardi, A. Saran, M. T. Ciotti, E. Ferretti, A. Gulino, S. Pazzaglia, et al. Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3 FASEB J, July 1, 2007; 21(9): 2215 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rittie, S. Kansra, S. W. Stoll, Y. Li, J. E. Gudjonsson, Y. Shao, L. E. Michael, G. J. Fisher, T. M. Johnson, and J. T. Elder Differential ErbB1 Signaling in Squamous Cell versus Basal Cell Carcinoma of the Skin Am. J. Pathol., June 1, 2007; 170(6): 2089 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sasai, J. T. Romer, H. Kimura, D. E. Eberhart, D. S. Rice, and T. Curran Medulloblastomas Derived from Cxcr6 Mutant Mice Respond to Treatment with a Smoothened Inhibitor Cancer Res., April 15, 2007; 67(8): 3871 - 3877. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Iacovelli, A. Arcella, G. Battaglia, S. Pazzaglia, E. Aronica, P. Spinsanti, A. Caruso, E. De Smaele, A. Saran, A. Gulino, et al. Pharmacological Activation of mGlu4 Metabotropic Glutamate Receptors Inhibits the Growth of Medulloblastomas. J. Neurosci., August 9, 2006; 26(32): 8388 - 8397. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hartmann, B. Digon-Sontgerath, A. Koch, A. Waha, E. Endl, I. Dani, D. Denkhaus, C. G. Goodyer, N. Sorensen, O. D. Wiestler, et al. Phosphatidylinositol 3'-Kinase/AKT Signaling Is Activated in Medulloblastoma Cell Proliferation and Is Associated with Reduced Expression of PTEN. Clin. Cancer Res., May 15, 2006; 12(10): 3019 - 3027. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Thompson, C. Fuller, T. L. Hogg, J. Dalton, D. Finkelstein, C. C. Lau, M. Chintagumpala, A. Adesina, D. M. Ashley, S. J. Kellie, et al. Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations J. Clin. Oncol., April 20, 2006; 24(12): 1924 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sasai, J. T. Romer, Y. Lee, D. Finkelstein, C. Fuller, P. J. McKinnon, and T. Curran Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies. Cancer Res., April 15, 2006; 66(8): 4215 - 4222. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Payne and C. J. Kemp Tumor suppressor genetics Carcinogenesis, December 1, 2005; 26(12): 2031 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Romer and T. Curran Targeting Medulloblastoma: Small-Molecule Inhibitors of the Sonic Hedgehog Pathway as Potential Cancer Therapeutics Cancer Res., June 15, 2005; 65(12): 4975 - 4978. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hartmann, A. Koch, H. Brune, A. Waha, U. Schuller, I. Dani, D. Denkhaus, W. Langmann, U. Bode, O. D. Wiestler, et al. Insulin-Like Growth Factor II Is Involved in the Proliferation Control of Medulloblastoma and Its Cerebellar Precursor Cells Am. J. Pathol., April 1, 2005; 166(4): 1153 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sanchez, A. M. Hernandez, B. Stecca, A. J. Kahler, A. M. DeGueme, A. Barrett, M. Beyna, M. W. Datta, S. Datta, and A. Ruiz i Altaba Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling PNAS, August 24, 2004; 101(34): 12561 - 12566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Couve-Privat, M. Le Bret, E. Traiffort, S. Queille, J. Coulombe, B. Bouadjar, M. F. Avril, M. Ruat, A. Sarasin, and L. Daya-Grosjean Functional Analysis of Novel Sonic Hedgehog Gene Mutations Identified in Basal Cell Carcinomas from Xeroderma Pigmentosum Patients Cancer Res., May 15, 2004; 64(10): 3559 - 3565. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lee, H. L. Miller, P. Jensen, R. Hernan, M. Connelly, C. Wetmore, F. Zindy, M. F. Roussel, T. Curran, R. J. Gilbertson, et al. A Molecular Fingerprint for Medulloblastoma Cancer Res., September 1, 2003; 63(17): 5428 - 5437. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hu, J. M. Bonifas, G. Aragon, L. Kopelovich, Y. Liang, S. Ohta, M. A. Israel, D. R. Bickers, M. Aszterbaum, and E. H. Epstein Jr. Evidence for Lack of Enhanced Hedgehog Target Gene Expression in Common Extracutaneous Tumors Cancer Res., March 1, 2003; 63(5): 923 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tate, M. Li, T. Suzuki, and T. Mitsuya A New Germline Mutation of the PTCH Gene in a Japanese Patient with Nevoid Basal Cell Carcinoma Syndrome Associated with Meningioma Jpn. J. Clin. Oncol., January 1, 2003; 33(1): 47 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Tong, H. Ohgaki, H. Huang, C. Granier, P. Kleihues, and Z.-Q. Wang Null Mutation of DNA Strand Break-Binding Molecule Poly(ADP-ribose) Polymerase Causes Medulloblastomas in p53-/- Mice Am. J. Pathol., January 1, 2003; 162(1): 343 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sheng, S. Goich, A. Wang, M. Grachtchouk, L. Lowe, R. Mo, K. Lin, F. J. de Sauvage, H. Sasaki, C.-c. Hui, et al. Dissecting the Oncogenic Potential of Gli2: Deletion of an NH2-Terminal Fragment Alters Skin Tumor Phenotype Cancer Res., September 15, 2002; 62(18): 5308 - 5316. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Bailey, L. Milenkovic, M. P. Scott, J. F. Collawn, and R. L. Johnson Several PATCHED1 Missense Mutations Display Activity in patched1-Deficient Fibroblasts J. Biol. Chem., September 6, 2002; 277(37): 33632 - 33640. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Berman, S. S. Karhadkar, A. R. Hallahan, J. I. Pritchard, C. G. Eberhart, D. N. Watkins, J. K. Chen, M. K. Cooper, J. Taipale, J. M. Olson, et al. Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade Science, August 30, 2002; 297(5586): 1559 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Solecki, M. Gromeier, S. Mueller, G. Bernhardt, and E. Wimmer Expression of the Human Poliovirus Receptor/CD155 Gene Is Activated by Sonic Hedgehog J. Biol. Chem., July 5, 2002; 277(28): 25697 - 25702. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dahmane, P. Sanchez, Y. Gitton, V. Palma, T. Sun, M. Beyna, H. Weiner, and A. Ruiz i Altaba The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis Development, December 15, 2001; 128(24): 5201 - 5212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xie, M. Aszterbaum, X. Zhang, J. M. Bonifas, C. Zachary, E. Epstein, and F. McCormick A role of PDGFRalpha in basal cell carcinoma proliferation PNAS, July 31, 2001; 98(16): 9255 - 9259. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, X. L. Ping, P. K. Lee, X. L. Wu, Y. J. Yao, M. J. Zhang, D. N. Silvers, D. Ratner, R. Malhotra, M. Peacocke, et al. Role of PTCH and p53 Genes in Early-Onset Basal Cell Carcinoma Am. J. Pathol., February 1, 2001; 158(2): 381 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lo Muzio A Possible Role for the Wnt~1 Pathway in Oral Carcinogenesis Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(2): 152 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.C. Barreto, R.S. Gomez, A.E. Bale, W.L. Boson, and L. De Marco PTCH Gene Mutations in Odontogenic Keratocysts Journal of Dental Research, June 1, 2000; 79(6): 1418 - 1422. [Abstract] [PDF] |
||||
![]() |
C. Wetmore, D. E. Eberhart, and T. Curran The Normal patched Allele Is Expressed in Medulloblastomas from Mice with Heterozygous Germ-Line Mutation of patched Cancer Res., April 1, 2000; 60(8): 2239 - 2246. [Abstract] [Full Text] |
||||
![]() |
H. B. Samat and J. H. Menkes How to Construct a Neural Tube J Child Neurol, February 1, 2000; 15(2): 110 - 124. [PDF] |
||||
![]() |
H. Huang, B. M. Mahler-Araujo, A. Sankila, L. Chimelli, Y. Yonekawa, P. Kleihues, and H. Ohgaki APC Mutations in Sporadic Medulloblastomas Am. J. Pathol., February 1, 2000; 156(2): 433 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kappler, T. Pietsch, S. Weggen, O. D. Wiestler, and H. Scherthan Chromosomal imbalances and DNA amplifications in SV40 large T antigen-induced primitive neuroectodermal tumor cell lines of the rat Carcinogenesis, August 1, 1999; 20(8): 1433 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D. Louro, P. McKie-Bell, H. Gosnell, B. C. Brindley, R. P. Bucy, and J. M. Ruppert The Zinc Finger Protein GLI Induces Cellular Sensitivity to the mTOR Inhibitor Rapamycin Cell Growth Differ., July 1, 1999; 10(7): 503 - 516. [Abstract] [Full Text] |
||||
![]() |
N. Bodak, S. Queille, M. F. Avril, B. Bouadjar, C. Drougard, A. Sarasin, and L. Daya-Grosjean High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum PNAS, April 27, 1999; 96(9): 5117 - 5122. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |